Gunderson Capital Management’s Teladoc Health TDOC Stock Holding History

Gunderson Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,379	Closed	-$2.08M	–	72
2020 Q4	$2.08M	Buy	+10,379	New	+$2.11M	1.36%	24
2020 Q3	–	Sell	-3,912	Closed	-$747K	–	60
2020 Q2	$747K	Sell	3,912 -182,703	-98%	-$32M	0.6%	44
2020 Q1	$8.57M	Buy	+186,615	New	+$21.7M	11.88%	1
2019 Q2	–	Sell	-11,003	Closed	-$612K	–	69
2019 Q1	$612K	Buy	+11,003	New	+$672K	0.53%	37

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DVF

Discovery Value Fund Singapore $39.8M AUM 27.89% 1-Year Est. Return

Gunderson Capital Management's TDOC Position: Q1 2021 in Review

Gunderson Capital Management sold out of Teladoc Health (TDOC) in Q1 2021, closing a stake of 10,379 shares — an estimated $2.08M sold.

Gunderson Capital Management first reported a position in TDOC in Q1 2019 and held it in 4 quarters. The position peaked at $8.57M in Q1 2020. 890 funds tracked by Wall St. Rank hold TDOC as of Q1 2021.

Gunderson Capital Management reported no remaining Teladoc Health position as of Q1 2021 after selling out during the quarter.
Gunderson Capital Management sold 10,379 Teladoc Health shares in Q1 2021, an estimated $2.08M.
Gunderson Capital Management first reported a position in Teladoc Health in Q1 2019 and held it in 4 quarters.
Gunderson Capital Management's Teladoc Health position peaked at $8.57M in Q1 2020.
890 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2021.

Based on Gunderson Capital Management's 13F filing for Q1 2021, filed 4 May 2021.